Smith & Nephew SNATS - 19 Year Stock Price History | SNN
Historical daily share price chart and data for Smith & Nephew SNATS since 1999 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Smith & Nephew SNATS as of November 12, 2018 is 36.42.
| Smith & Nephew SNATS Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2018 | 36.1312 | 34.4828 | 39.4400 | 32.4000 | 36.4200 | 5.29% |
| 2017 | 33.4499 | 29.0858 | 38.0397 | 28.9985 | 34.5914 | 18.57% |
| 2016 | 31.1232 | 33.1236 | 33.7470 | 26.2926 | 29.1731 | -13.91% |
| 2015 | 33.0517 | 33.6230 | 35.7159 | 30.9154 | 33.8851 | -1.39% |
| 2014 | 30.5152 | 26.0153 | 36.1359 | 26.0153 | 34.3619 | 30.43% |
| 2013 | 21.8304 | 20.0105 | 26.3862 | 18.9943 | 26.3458 | 32.44% |
| 2012 | 18.0384 | 17.2067 | 19.9854 | 16.0383 | 19.8920 | 17.38% |
| 2011 | 17.9354 | 18.2290 | 20.8594 | 14.7383 | 16.9463 | -6.95% |
| 2010 | 16.4458 | 17.6319 | 18.4208 | 14.2157 | 18.2117 | 4.05% |
| 2009 | 13.4541 | 10.9359 | 17.5465 | 10.2549 | 17.5021 | 61.53% |
| 2008 | 18.0569 | 19.1150 | 22.7437 | 10.1945 | 10.8353 | -43.11% |
| 2007 | 19.9087 | 17.2136 | 22.4783 | 17.1150 | 19.0454 | 10.73% |
| 2006 | 14.5628 | 15.3935 | 17.3056 | 12.0911 | 17.2004 | 14.17% |
| 2005 | 15.5125 | 16.3482 | 16.9962 | 13.0858 | 15.0652 | -9.50% |
| 2004 | 15.7267 | 13.3335 | 18.5782 | 13.0021 | 16.6474 | 24.62% |
| 2003 | 10.4821 | 9.7396 | 13.4801 | 8.4391 | 13.3590 | 38.19% |
| 2002 | 9.0756 | 9.3830 | 10.0164 | 7.5856 | 9.6672 | 2.18% |
| 2001 | 7.7082 | 7.0575 | 9.4764 | 6.4208 | 9.4608 | 33.70% |
| 2000 | 6.0216 | 6.1602 | 7.0759 | 4.6837 | 7.0759 | 14.63% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.143B | $4.765B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $127.843B | 25.90 |
| Medtronic (MDT) | Ireland | $127.434B | 19.54 |
| Stryker (SYK) | United States | $64.080B | 24.15 |
| Boston Scientific (BSX) | United States | $53.415B | 26.99 |
| Baxter (BAX) | United States | $33.780B | 21.81 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.992B | 15.56 |
| ResMed (RMD) | United States | $15.239B | 29.06 |
| Canopy Growth (CGC) | Canada | $9.087B | 0.00 |
| Perrigo (PRGO) | Ireland | $8.704B | 13.21 |
| Bio-Rad Laboratories (BIO) | United States | $8.282B | 52.95 |
| Aurora Cannabis (ACB) | Canada | $7.005B | 66.27 |
| Hill-Rom Holdings (HRC) | United States | $6.451B | 20.45 |
| Haemonetics (HAE) | United States | $5.768B | 50.73 |
| Insulet (PODD) | United States | $5.175B | 0.00 |
| ICU Medical (ICUI) | United States | $4.749B | 26.49 |
| Hutchison China MediTech (HCM) | China | $4.266B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.158B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $4.020B | 0.00 |
| Neogen (NEOG) | United States | $3.320B | 50.28 |
| National Vision Holdings (EYE) | United States | $3.309B | 73.08 |
| Aphria (APHA) | $3.074B | 0.00 | |
| NuVasive (NUVA) | United States | $2.979B | 27.72 |
| Quidel (QDEL) | United States | $2.599B | 33.88 |
| NxStage Medical (NXTM) | United States | $1.933B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.498B | 21.20 |
| AtriCure (ATRC) | United States | $1.262B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.079B | 1554.50 |
| VAREX IMAGING (VREX) | United States | $1.035B | 16.91 |
| PetIQ (PETQ) | United States | $0.874B | 28.60 |
| Surmodics (SRDX) | United States | $0.855B | 130.61 |
| Meridian Bioscience (VIVO) | United States | $0.836B | 26.65 |
| OraSure Technologies (OSUR) | United States | $0.797B | 44.86 |
| Cerus (CERS) | United States | $0.778B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.775B | 24.86 |
| MacroGenics (MGNX) | United States | $0.734B | 0.00 |
| Omeros (OMER) | United States | $0.638B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.575B | 17.81 |
| Insys Therapeutics (INSY) | United States | $0.568B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 6.41 |
| LeMaitre Vascular (LMAT) | United States | $0.527B | 25.89 |
| NanoString Technologies (NSTG) | United States | $0.475B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.459B | 0.00 |
| Evolus (EOLS) | United States | $0.416B | 0.00 |
| Quanterix (QTRX) | United States | $0.372B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.327B | 21.12 |
| Cytosorbents (CTSO) | United States | $0.312B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.280B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.258B | 348.50 |
| Surface Oncology (SURF) | United States | $0.227B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.225B | 0.00 |
| Chimerix (CMRX) | United States | $0.168B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.162B | 0.00 |
| Fonar (FONR) | United States | $0.143B | 7.20 |
| Chembio Diagnostics (CEMI) | United States | $0.117B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.091B | 0.00 |
| United-Guardian (UG) | United States | $0.080B | 16.85 |
| Female Health (VERU) | United States | $0.077B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.074B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.068B | 21.60 |
| Neurotrope (NTRP) | United States | $0.055B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.042B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.030B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.027B | 0.00 |
| Senestech (SNES) | United States | $0.020B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.000B | 0.00 |
